The pharmacological research of Tek-1 relevance to anti-neuroinflammation, a candidate compound based on Telmisartan

• Autorzy: Jianbo Yang , Changcong Cui
• Języki publikacji: EN

Abstrakty

EN

In this paper, BV-2 mouse small glial cell inflammation model induced by LPS is established. The experiment used 0.1-10 μM of telmisartan and Tek-1 to incubate with small glial cell and used telmisartan and Tek-1 to incubate with PPAR gamma special heterosexual antagonistic anti-agent GW9662. The article used ELISA method to dectect TNF-a effect on small glial cell for telmisartan and Tek-1. The article used real-time quantitative PCR method to dectect mRNA level expression effect of CD11b, CD16 and iNOS on small glial cell for telmisartan and Tek-1 and used Western Blot method to dectect MAPKs signal pathway and NF-κb signal turned guide pathway effect on small glial cell for telmisartan and Tek-1. Results show that Tek-1 had high affinity with AT1 receptor and inhibited intracellular calcium ion activation which can be for the AT1 receptor antagonists. Meanwhile, Tek-1 can partially activate PPAR gamma compared with full agonists of rosiglitazone.

Słowa kluczowe

EN

Cartilage rhinoplasty; Goldman technique; Broad nasal tip; Dome-splitting

• Czasopismo: Open Medicine
• Rocznik: 2014
• Tom: 10
• Numer: 1

Daty

wydano

2015-01-01

otrzymano

2015-07-10

zaakceptowano

2015-10-14

online

2015-12-17

Twórcy

autor

Jianbo Yang

• Department of Neurology, Xian Jiao Tong University, Postal code 710061, China,

autor

Changcong Cui

• Department of Vasculocardiology, Xian Jiao Tong University, Postal code 710061, China

Bibliografia

• [1] Cameron B., Landreth G.E., Inflammation, microglia, and Alzheimer’s disease, Neurobiol Dis., 2010, 37(3), 503-509[WoS][Crossref]
• [2] Lue L.F., et al., Microglia activation and anti-inflammatory regulation in Alzheimer’s disease, Mol. Neurobiol., 2010, 41(2-3), 115-128[WoS][Crossref]
• [3] Joglar B., Rodriguez-Pallares J., et al., The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease, J. Neurochem., 2009, 109, 656-669[WoS]
• [4] Lu Q., Zhu Y.Z., et al., Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats, Neuroreport, 2005, 16, 1963-1967
• [5] Jung W.K., et al., Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases, Br. J. Pharmacol., 2010, 159(6), 1274-1285[WoS]
• [6] Nagai Y., Akashi S., et al., Essential role of MD-2 in LPS responsiveness and TLR4 distribution, Nat. Immunol., 2002, 3(7), 667-672
• [7] Storer P.D., et al., Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis, J. Neuroimmunol., 2005, 161(1-2), 113-122
• [8] Wang Y., et al., T33 a novel peroxisome proliferator-activated receptor gamma/alpha agonist, exerts neuroprotective action via its anti-inflammatory activities, Act. Pharmacol. Sin., 2011, 32(9), 1100-1108[Crossref]
• [9] Garrido-Gil, et al., Involvement of PPAR-γ in the Neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson’s disease, Journal of Neuroinflammation, 2012, 9, 38[WoS]
• [10] Xiao J., Leung J.C., et al., Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy, Clin. Immunol., 2009, 132, 266-276[WoS]
• [11] Pacher P., Beckman J.S., et al., Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 2007, 87(1), 315-424[Crossref][WoS]
• [12] Aloisi F., Immune function of microglia, Glia, 2001, 36(2), 165-179[Crossref]
• [13] Pearson Q., Beers G.T., et al., Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr. Rev., 2001, 22(2), 153-183
• [14] Chow Y.L., et al., Cardamom from Alpena rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappaB signaling pathway, Int. Immunopharmacol, 2012, 12(4), 657-65[Crossref]

Identyfikatory

DOI

10.1515/med-2015-0077